Julio Lamprea Montealegre, MD, PhD, MPH
|
Title(s) | Assistant Professor, Medicine |
---|
School | School of Medicine |
---|
Address | 35 Medical Center Way, #001 San Francisco CA 94143
|
---|
Pronouns | He/Him/His |
---|
ORCID
| 0000-0002-5999-4287 |
---|
vCard | Download vCard |
---|
|
|
Biography
Universidad Javeriana, Bogota, Colombia | MD | 06/2006 | |
Johns Hopkins , Baltimore | MPH | 06/2009 | Epidemiology & Biostatistics |
Johns Hopkins, Baltimore | PhD | 06/2012 | Cardiovascular Epidemiology |
University of Maryland, Baltimore | Residency | 06/2015 | Internal Medicine |
University of Washington, Seattle | Fellowship | 06/2018 | Cardiology |
Overview
Dr. Lamprea-Montealegre is a cardiologist who focuses on preventive cardiology. His clinical interests include preventive cardiology and cardiovascular risk assessment, cardiorenal syndrome, dyslipidemias , heart valve disease, and echocardiography.
Dr. Lamprea-Montealegre's research focuses on the cardiovascular health consequences of chronic kidney disease. His current projects aim to prevent cardiovascular disease through the early detection and treatment of chronic kidney disease.
Research
ORNG Applications
Featured Content
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Challenges and Strategies in Implementing Novel Kidney Protective and Cardioprotective Therapies in Patients With Diabetes and Kidney Disease. Semin Nephrol. 2024 Mar; 44(2):151520.
Limonte CP, Lamprea-Montealegre JA, Tuttle KR. PMID: 38705774; PMCID: PMC11283968.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Cystatin C Use for CKD Detection in the Veterans Health Administration System: A Qualitative Study of Barriers and Facilitators. Kidney Med. 2024 Jun; 6(6):100830.
Lamprea-Montealegre JA, Shapiro A, Bontrager NAB, Rifkin DE, Jassal SK, Gregg LP, Navaneethan SD, Navarra K, Shlipak MG, Estrella MM, Wang V. PMID: 38799784; PMCID: PMC11127258.
View in:
PubMed Mentions:
-
Assessing community-level impacts of and responses to stay at home orders: The King County COVID-19 community study. PLoS One. 2024; 19(2):e0296851.
Moloney K, Lamprea Montealegre JA, Busch Isaksen TM, Kennedy M, Archer M, Contreras C, Iyaz D, Randazza J, Silva J, Errett NA. PMID: 38330074; PMCID: PMC10852336.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansPHPublic Health
-
Unlocking the potential: boosting SGLT2 inhibitor uptake to prevent the cardiorenal consequences of chronic kidney disease. Lancet Reg Health West Pac. 2024 Feb; 43:101004.
Lamprea-Montealegre JA. PMID: 38292307; PMCID: PMC10827533.
View in:
PubMed Mentions:
-
Population-wide albuminuria screening: implications for CKD detection and management. Lancet. 2023 09 23; 402(10407):1020-1021.
Lamprea-Montealegre JA, Estrella MM. PMID: 37597525.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease. JAMA Netw Open. 2023 07 03; 6(7):e2326230.
Chu CD, Xia F, Du Y, Singh R, Tuot DS, Lamprea-Montealegre JA, Gualtieri R, Liao N, Kong SX, Williamson T, Shlipak MG, Estrella MM. PMID: 37498594; PMCID: PMC10375308.
View in:
PubMed Mentions:
18 Fields:
Translation:
Humans
-
Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease. Diabetes Care. 2022 12 01; 45(12):2900-2906.
Lamprea-Montealegre JA, Madden E, Tummalapalli SL, Chu CD, Peralta CA, Du Y, Singh R, Kong SX, Tuot DS, Shlipak MG, Estrella MM. PMID: 36156061; PMCID: PMC9998844.
View in:
PubMed Mentions:
12 Fields:
Translation:
Humans
-
Launching a career as a physician-scientist. Heart. 2022 10 28; 108(22):1832-1833.
Lamprea-Montealegre JA, Natarajan P. PMID: 36307207.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol. BMC Nephrol. 2022 10 12; 23(1):331.
Lamprea-Montealegre JA, Joshi P, Shapiro AS, Madden E, Navarra K, Potok OA, Gregg LP, Podchiyska T, Robinson A, Goldstein MK, Peralta CA, Jassal SK, Navaneethan SD, Rifkin DE, Wang V, Shlipak MG, Estrella MM. PMID: 36224528; PMCID: PMC9554861.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System. JAMA. 2022 09 06; 328(9):861-871.
Lamprea-Montealegre JA, Madden E, Tummalapalli SL, Peralta C, Neilands TB, Garcia PK, Muiru A, Karliner L, Shlipak MG, Estrella MM. PMID: 36066519; PMCID: PMC9449794.
View in:
PubMed Mentions:
24 Fields:
Translation:
Humans
-
Plasma Levels of Advanced Glycation Endproducts and Risk of Cardiovascular Events: Findings From 2 Prospective Cohorts. J Am Heart Assoc. 2022 08 02; 11(15):e024012.
Lamprea-Montealegre JA, Arnold AM, McCLelland RL, Mukamal KJ, Djousse L, Biggs ML, Siscovick DS, Tracy RP, Beisswenger PJ, Psaty BM, Ix JH, Kizer JR. PMID: 35904195; PMCID: PMC9375486.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Improving cardiovascular health through healthy lifestyle behaviours: time to think beyond willpower. Heart. 2022 04; 108(7):496-497.
Lamprea-Montealegre JA. PMID: 35121577.
View in:
PubMed Mentions: Fields:
Translation:
Humans
-
Too Many for Too Few: Finding Appropriate Nephrology Referrals for Patients With CKD That Optimize Outcomes. Am J Kidney Dis. 2022 03; 79(3):330-332.
Chu CD, Lamprea-Montealegre JA, Estrella MM. PMID: 35031165.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Valvular Heart Disease in Relation to Race and Ethnicity: JACC Focus Seminar 4/9. J Am Coll Cardiol. 2021 12 14; 78(24):2493-2504.
Lamprea-Montealegre JA, Oyetunji S, Bagur R, Otto CM. PMID: 34886971.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types. JAMA Health Forum. 2021; 2(12):e214205.
Sri Lekha Tummalapalli; Julio Lamprea Montealegre; Neil Warnock; Michael Green; Said A. Ibrahim; Michelle M. Estrella. .
-
Triglyceride-Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End-Stage Renal Disease on Hemodialysis. Am J Cardiol. 2021 08 01; 152:63-68.
Lamprea-Montealegre JA, Katz R, Scharnagl H, Silbernagel G, März W, Drechsler C, Wanner C, de Boer IH. PMID: 34108090.
View in:
PubMed Mentions:
2 Fields:
Translation:
Humans
-
Aortic and mitral valve calcification as markers of atherosclerotic cardiovascular disease risk. Eur Heart J Cardiovasc Imaging. 2021 02 22; 22(3):271-272.
Lamprea-Montealegre JA, Otto CM. PMID: 33164050.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention. Heart. 2021 08; 107(16):1282-1288.
Lamprea-Montealegre JA, Shlipak MG, Estrella MM. PMID: 33568433.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD. Clin J Am Soc Nephrol. 2020 01 07; 15(1):47-60.
Lamprea-Montealegre JA, Staplin N, Herrington WG, Haynes R, Emberson J, Baigent C, de Boer IH, SHARP Collaborative Group. PMID: 31831577; PMCID: PMC6946066.
View in:
PubMed Mentions:
27 Fields:
Translation:
Humans
-
Association of High-Density Lipoprotein Particles and High-Density Lipoprotein Apolipoprotein C-III Content With Cardiovascular Disease Risk According to Kidney Function: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2019 12 17; 8(24):e013713.
Lamprea-Montealegre JA, McClelland RL, Otvos JD, Mora S, Koch M, Jensen MK, de Boer IH. PMID: 31818211; PMCID: PMC6951074.
View in:
PubMed Mentions:
9 Fields:
Translation:
Humans
-
Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2019 08 06; 8(15):e012200.
Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, Christenson R, Seliger SL, Soliman EZ, Deo R, Ky B, Feldman HI, Kusek JW, deFilippi CR, Wolf MS, Shafi T, Go AS, Bansal N, CRIC Study Investigators. PMID: 31379242; PMCID: PMC6761652.
View in:
PubMed Mentions:
20 Fields:
Translation:
Humans
-
Prevalence of Hypertension and Cardiovascular Risk According to Blood Pressure Thresholds Used for Diagnosis. Hypertension. 2018 09; 72(3):602-609.
Lamprea-Montealegre JA, Zelnick LR, Hall YN, Bansal N, de Boer IH. PMID: 30354757; PMCID: PMC6205214.
View in:
PubMed Mentions:
22 Fields:
Translation:
Humans
-
Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes. Diabetes Care. 2018 06; 41(6):1132-1133.
Lamprea-Montealegre JA, de Boer IH. PMID: 29784697; PMCID: PMC6463735.
View in:
PubMed Mentions:
3 Fields:
-
Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients. BMC Nephrol. 2018 05 03; 19(1):107.
Boulware LE, Ephraim PL, Ameling J, Lewis-Boyer L, Rabb H, Greer RC, Crews DC, Jaar BG, Auguste P, Purnell TS, Lamprea-Monteleagre JA, Olufade T, Gimenez L, Cook C, Campbell T, Woodall A, Ramamurthi H, Davenport CA, Choudhury KR, Weir MR, Hanes DS, Wang NY, Vilme H, Powe NR. PMID: 29724177; PMCID: PMC5934897.
View in:
PubMed Mentions:
22 Fields:
Translation:
Humans
-
Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease. Heart. 2018 09; 104(17):1455-1460.
Lamprea-Montealegre JA, McClelland RL, Grams M, Ouyang P, Szklo M, de Boer IH. PMID: 29472290.
View in:
PubMed Mentions:
11 Fields:
Translation:
Humans
-
Health Behaviors and Calcific Aortic Valve Disease. J Am Heart Assoc. 2018 02 03; 7(3).
Lamprea-Montealegre JA, Otto CM. PMID: 29431108; PMCID: PMC5850268.
View in:
PubMed Mentions:
4 Fields:
Translation:
Humans
-
Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study. Atherosclerosis. 2014 May; 234(1):42-6.
Lamprea-Montealegre JA, Sharrett AR, Matsushita K, Selvin E, Szklo M, Astor BC. PMID: 24607852.
View in:
PubMed Mentions:
29 Fields:
Translation:
Humans
-
Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review. Am J Kidney Dis. 2013 Nov; 62(5):953-73.
Purnell TS, Auguste P, Crews DC, Lamprea-Montealegre J, Olufade T, Greer R, Ephraim P, Sheu J, Kostecki D, Powe NR, Rabb H, Jaar B, Boulware LE. PMID: 23725972; PMCID: PMC3809150.
View in:
PubMed Mentions:
103 Fields:
Translation:
Humans
-
Chronic kidney disease, plasma lipoproteins, and coronary artery calcium incidence: the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2013 Mar; 33(3):652-8.
Lamprea-Montealegre JA, McClelland RL, Astor BC, Matsushita K, Shlipak M, de Boer IH, Szklo M. PMID: 23329135.
View in:
PubMed Mentions:
19 Fields:
Translation:
Humans
-
CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol. 2012 Nov; 7(11):1777-85.
Lamprea-Montealegre JA, Astor BC, McClelland RL, de Boer IH, Burke GL, Sibley CT, O'Leary D, Sharrett AR, Szklo M. PMID: 22879436; PMCID: PMC3488943.
View in:
PubMed Mentions:
15 Fields:
Translation:
Humans
-
Validity in scale-testing. 2007; 36(2):340-348.
Lamprea-Montealegre JA, Gomez-Restrepo C. View Publication.
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
Year | Publications |
---|
2007 | 1 |
2012 | 1 |
2013 | 2 |
2014 | 1 |
2018 | 5 |
2019 | 3 |
2021 | 5 |
2022 | 7 |
2023 | 2 |
2024 | 4 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs